Correlation Between Tesla and CytomX Therapeutics
Can any of the company-specific risk be diversified away by investing in both Tesla and CytomX Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tesla and CytomX Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tesla Inc and CytomX Therapeutics, you can compare the effects of market volatilities on Tesla and CytomX Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tesla with a short position of CytomX Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tesla and CytomX Therapeutics.
Diversification Opportunities for Tesla and CytomX Therapeutics
-0.77 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Tesla and CytomX is -0.77. Overlapping area represents the amount of risk that can be diversified away by holding Tesla Inc and CytomX Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CytomX Therapeutics and Tesla is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tesla Inc are associated (or correlated) with CytomX Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CytomX Therapeutics has no effect on the direction of Tesla i.e., Tesla and CytomX Therapeutics go up and down completely randomly.
Pair Corralation between Tesla and CytomX Therapeutics
Given the investment horizon of 90 days Tesla is expected to generate 1.04 times less return on investment than CytomX Therapeutics. But when comparing it to its historical volatility, Tesla Inc is 2.89 times less risky than CytomX Therapeutics. It trades about 0.05 of its potential returns per unit of risk. CytomX Therapeutics is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 164.00 in CytomX Therapeutics on August 27, 2024 and sell it today you would lose (75.00) from holding CytomX Therapeutics or give up 45.73% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Tesla Inc vs. CytomX Therapeutics
Performance |
| Timeline |
| Tesla Inc |
| CytomX Therapeutics |
Tesla and CytomX Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tesla and CytomX Therapeutics
The main advantage of trading using opposite Tesla and CytomX Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tesla position performs unexpectedly, CytomX Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CytomX Therapeutics will offset losses from the drop in CytomX Therapeutics' long position.The idea behind Tesla Inc and CytomX Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| CytomX Therapeutics vs. Eliem Therapeutics | CytomX Therapeutics vs. HCW Biologics | CytomX Therapeutics vs. Scpharmaceuticals | CytomX Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |